Stocks and Investing Stocks and Investing
Wed, February 8, 2023

Chris Howerton Downgraded (AVTX) to Sell and Held Target at $720 on, Feb 8th, 2023


Published on 2024-10-28 01:28:05 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Downgraded "Avalo Therapeutics, Inc." (AVTX) to Sell and Held Target at $720 on, Feb 8th, 2023.

Chris, nor any peers, have made any analyst calls on AVTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources